Chronic intermittent hypoxia induces atherosclerosis via activation of adipose angiopoietin-like 4.
about
Roles and Mechanisms of Obstructive Sleep Apnea-Hypopnea Syndrome and Chronic Intermittent Hypoxia in Atherosclerosis: Evidence and ProspectiveObstructive sleep apnea as a risk factor for type 2 diabetes mellitusInsulin resistance, glucose intolerance and diabetes mellitus in obstructive sleep apnoeaChronic intermittent hypoxia and obstructive sleep apnea: an experimental and clinical approachThe impact of sleep disorders on glucose metabolism: endocrine and molecular mechanismsObesity, Cardiovascular Disease and Sleep Disorders: Insights into the Rising Epidemic.Male fertility is reduced by chronic intermittent hypoxia mimicking sleep apnea in miceDoes airway surgery lower serum lipid levels in obstructive sleep apnea patients? A retrospective case review.Association of fat density with subclinical atherosclerosis.Inflammation in sleep apnea: an update.Obstructive sleep apnoea syndrome: a new paradigm by chronic nocturnal intermittent hypoxia and sleep disruption.Obstructive sleep apnea: a cardiometabolic risk in obesity and the metabolic syndrome.Protocatechuic acid ameliorates neurocognitive functions impairment induced by chronic intermittent hypoxia.The Effect of Adenotonsillectomy for Childhood Sleep Apnea on Cardiometabolic Measures.Lysyl Oxidase as a Serum Biomarker of Liver Fibrosis in Patients with Severe Obesity and Obstructive Sleep Apnea.Metabolic dysfunction in obstructive sleep apnea: A critical examination of underlying mechanismsEffect of chronic intermittent hypoxia on triglyceride uptake in different tissues.Translational approaches to understanding metabolic dysfunction and cardiovascular consequences of obstructive sleep apnea.Sleep Apnea Research in Animals. Past, Present, and Future.Objectively measured sleep characteristics and prevalence of coronary artery calcification: the Multi-Ethnic Study of Atherosclerosis Sleep study.Adipose tissue angiogenesis: impact on obesity and type-2 diabetes.Loss of von Hippel-Lindau protein (VHL) increases systemic cholesterol levels through targeting hypoxia-inducible factor 2α and regulation of bile acid homeostasis.Sleep-disordered breathing, type 2 diabetes and the metabolic syndrome.Chronic intermittent hypoxia exposure-induced atherosclerosis: a brief review.Biological plausibility linking sleep apnoea and metabolic dysfunction.Targeting the ROS-HIF-1-endothelin axis as a therapeutic approach for the treatment of obstructive sleep apnea-related cardiovascular complications.Adipose tissue inflammation by intermittent hypoxia: mechanistic link between obstructive sleep apnoea and metabolic dysfunction.OSA and cardiometabolic risk: What's the bottom line?Multiple Roles of Angiopoietin-Like 4 in Osteolytic DiseaseCirculating exosomes in obstructive sleep apnea as phenotypic biomarkers and mechanistic messengers of end-organ morbidity.Endothelin regulates intermittent hypoxia-induced lipolytic remodelling of adipose tissue and phosphorylation of hormone-sensitive lipase.Intermittent hypoxia-induced insulin resistance is associated with alterations in white fat distribution.The effect of adrenal medullectomy on metabolic responses to chronic intermittent hypoxia.A randomised, controlled, crossover study of the effect of diet on angiopoietin-like protein 4 (ANGPTL4) through modification of the gut microbiome.Intermittent hypoxia induces murine macrophage foam cell formation by IKK-β-dependent NF-κB pathway activation.Update in sleep medicine 2013.Epicardial adipose tissue density and volume are related to subclinical atherosclerosis, inflammation and major adverse cardiac events in asymptomatic subjects.AJRCCM: 100-Year Anniversary. Sleep-Disordered Breathing: Still the New Kid on the Block.Prolonged Exposures to Intermittent Hypoxia Promote Visceral White Adipose Tissue Inflammation in a Murine Model of Severe Sleep Apnea: Effect of Normoxic Recovery.Angiopoietin-Like Protein 4 Is a High-Density Lipoprotein (HDL) Component for HDL Metabolism and Function in Nondiabetic Participants and Type-2 Diabetic Patients.
P2860
Q26746944-DCF3C2B9-5ED5-4B22-ADD5-3AF48CC4DA2EQ26778430-F0AD35E5-A3EC-46BD-8327-D0238FC13727Q26783727-8C9F7B2D-E661-4169-81F0-61900D16D221Q28076146-A83A7702-BA6E-42CB-961F-7C2313784B7FQ28390983-55C013A6-9481-4909-8B07-073F500A0C1AQ33811972-C47C8533-2D28-4055-A92D-B2E5A6A1C806Q34333884-1A15F126-D9AB-4C1C-B708-E824804EE32FQ34742943-E93565BB-7BBA-49D4-B852-4371E70D764BQ35026206-4C9E3C44-B650-4278-A71F-1D218FCFAAE7Q35137720-F497EE07-75B9-4169-BD79-14B10F42E726Q35645816-FE927B9E-3FB7-48CC-A151-14E1B9A8421EQ35704508-049AC7D1-15EE-43F6-BFC5-AF45ACFCA73DQ35792323-333C89ED-75A3-47BC-AC54-31A0E3AE71EFQ35936334-F46EAB0E-444B-4EDB-992D-29264F027011Q36076679-38D04725-57EE-45E5-9A91-6BB90010CA36Q36093354-DF9BDAAE-79EE-44B1-B534-54250C33A5BCQ36709586-FD0C77CE-DFB3-422D-BCF7-8C916C243D37Q36752050-0B985A8A-E6D0-4719-A083-DA241A2D70ECQ36765905-9140FD85-9F8B-4D05-8861-09A57296AEF5Q36874144-8CCEC898-4955-4749-B4FB-C177DC90E1E5Q37352210-5BFD1764-676A-4CFA-B0B2-E96EB1FD0F11Q37713582-BB4546DB-FD7C-4AC7-A9F6-47AB49E2D696Q38256622-EC14ADB1-8A39-4EED-8C4E-7E9B855AF1A9Q38593059-8AA6C230-CB2C-4909-824C-FF3436289F7CQ38759460-A561F0F6-14E4-470C-A9EF-AA0A0D9FC3E4Q38919168-68FCF022-BFB9-4821-BA57-9DF1589265F2Q39024401-B0EC47F0-78BF-4132-876E-DB1040C29BEBQ39120083-88C2CDF4-4C2E-4E59-9003-EA1600E1FB03Q39274312-ABF44125-2C45-4CFD-BFF6-DBF905C19F84Q39413926-3A87C3D2-1149-48B0-8855-2A1928E121F9Q40216017-2040F136-8C00-4606-846A-012F9FA4A85BQ41323114-56D31850-86B9-41B1-AB7A-F080B190896EQ42082788-AEFF09B5-9303-4B0A-B214-FBF323448C34Q42210874-0BEDC247-B658-4359-AEEE-BC5DAB1AE3BCQ42356964-1E771D5B-6690-4070-8A20-007E559483ABQ43464268-03F32DC6-ED29-465A-AB0A-680DE48E4D99Q46066018-D1C38429-DC7E-45C7-8767-C405CC137969Q46095460-AB20A3E9-B7A4-4372-9356-DCB7F23D897FQ46617003-03731E0A-3857-4D33-A3DF-B6EF0107AD00Q46645296-734D4110-DD28-4CF8-ADA1-866BD00E3E71
P2860
Chronic intermittent hypoxia induces atherosclerosis via activation of adipose angiopoietin-like 4.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on July 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Chronic intermittent hypoxia i ...... f adipose angiopoietin-like 4.
@en
Chronic intermittent hypoxia i ...... f adipose angiopoietin-like 4.
@nl
type
label
Chronic intermittent hypoxia i ...... f adipose angiopoietin-like 4.
@en
Chronic intermittent hypoxia i ...... f adipose angiopoietin-like 4.
@nl
prefLabel
Chronic intermittent hypoxia i ...... f adipose angiopoietin-like 4.
@en
Chronic intermittent hypoxia i ...... f adipose angiopoietin-like 4.
@nl
P2093
P2860
P1476
Chronic intermittent hypoxia i ...... f adipose angiopoietin-like 4.
@en
P2093
Alan R Schwartz
Allen C Myers
David R Powell
Jonathan C Jun
Karen L Hernandez
Luciano F Drager
Mi-Kyung Shin
Nils Halberg
Philipp E Scherer
P2860
P304
P356
10.1164/RCCM.201209-1688OC
P407
P577
2013-07-01T00:00:00Z